Nexalin Technology: Greenlight holds 133K shares
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Nexalin Technology, Inc. (NXL) reports Greenlight Ventures, LLC, a 10% owner, directly held 133,475 common shares as of November 10, 2026. The shares were issued in three tranches as consideration for the sale of PONM, Inc. to Nexalin under a Stock Purchase Agreement dated May 11, 2026: 31,967 shares on May 14, 2026; 14,207 on August 18, 2026; and 87,301 on November 10, 2026. The reported share count gives effect to Nexalin’s 1-for-30 reverse stock split effective August 28, 2026.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Holding | Common Stock, par value $0.001 per share F1 | -- | -- | -- |
Footnotes (1)
- F1. Consists of 133,475 shares of Common Stock held directly by Greenlight Ventures, LLC (giving effect to the Issuer's 1-for-30 reverse stock split effective August 28, 2026), comprising: (i) 31,967 shares issued on May 14, 2026 (Tranche 1), (ii) 14,207 shares issued on August 18, 2026 (Tranche 2), and (iii) 87,301 shares issued on November 10, 2026 (Tranche 3) as consideration for the sale of PONM, Inc. to the Issuer pursuant to the Stock Purchase Agreement dated May 11, 2026 (the "Purchase Agreement").
Key Figures
Key Terms
reverse stock split technical
Stock Purchase Agreement technical
Tranche technical
par value financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
AI-generated analysis. How Rhea-AI works. Not financial advice.